| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.08 | 0.09 |